Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sen. Gregg Plans Clinical Trials Legislation For This Congressional Session

This article was originally published in The Pink Sheet Daily

Executive Summary

The Senate Health Committee chairman’s bill would focus on “clinical trial database issues,” while legislation planned by Sens. Kennedy, Dodd and Johnson would be directed at FDA’s authority to disclose clinical trial results, a committee staffer says.

You may also be interested in...



Sen. Grassley Plans Legislation On Independence Of FDA Drug Safety Office

Finance Committee chair acknowledges he does not have enough votes for such legislation but says he is starting the "process of educating my colleagues" and "intends to continue that until we get this job done." Grassley's requested GAO report on the Office of Drug Safety will take several months.

Sen. Grassley Plans Legislation On Independence Of FDA Drug Safety Office

Finance Committee chair acknowledges he does not have enough votes for such legislation but says he is starting the "process of educating my colleagues" and "intends to continue that until we get this job done." Grassley's requested GAO report on the Office of Drug Safety will take several months.

FDA Oversight Of DTC Ads Will Be Examined By HHS Inspector General

The Inspector General will determine the effectiveness of FDA procedures for monitoring DTC ads and what actions are taken against companies with false and misleading ads, the IG’s fiscal 2005 work plan says. FDA’s handling of off-label drug promotions will also be studied.

Related Content

Topics

UsernamePublicRestriction

Register

PS058037

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel